PRODUCT SPOTLIGHT: QuidelOrtho
When patients present with respiratory symptoms, healthcare providers need answers quickly. The QUICKVUE™ Influenza + SARS Test from QuidelOrtho is designed to help healthcare providers obtain results in
10 minutes and make timely testing decisions.
The CLIA-waived, instrument-free test delivers results in 10 minutes, allowing providers to obtain information during the patient visit rather than waiting for results from a laboratory. The test uses a single nasal swab to detect Influenza A, Influenza B and SARS-CoV-2, helping providers differentiate among three common respiratory infections with one test.
For healthcare organizations focused on value-based care, rapid diagnostic information available during the patient visit can support treatment and patient management decisions. The ability to detect and differentiate Influenza A, Influenza B and SARS-CoV-2 from a single nasal swab may help providers more quickly evaluate patients presenting with respiratory symptoms.
For medical-surgical sales representatives, the product offers an opportunity to start a conversation around a familiar challenge: How quickly can a practice determine whether a patient’s respiratory symptoms are caused by flu or COVID-19?
Reps can also ask whether customers are currently running separate tests for influenza and COVID-19, and whether combining those capabilities into a single test could streamline their workflow.
Another useful question: How important is it for providers to have results while the patient is still in the office so treatment decisions can be made right away?
By combining dual detection, a 10-minute turnaround time and instrument-free, CLIA-waived testing, the QUICKVUE Influenza + SARS Test gives providers a practical point-of-care option for respiratory testing, and gives reps a straightforward way to discuss speed, workflow and patient care with customers.